Scutellarin inhibits translocation of protein kinase C in diabetic thoracic aorta of the rat

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 2, 2012, Pages 136-140

  Su, Yingxue ^a   Liu, Wei ^a   Ma, Li ^a   Liu, Xiaochang ^a   Liu, Zhaochun ^a   Zhu, Banghao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Protein kinase C; Scutellarin; Thoracic aortic smooth muscle cells; Translocation

Indexed keywords

AMINOGUANIDINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; SCUTELLARIN; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; ARTICLE; CELL CULTURE; CELL FRACTIONATION; CELL ISOLATION; CELL MEMBRANE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LOCALIZATION; FEEDING; GENE TRANSLOCATION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; RAT; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES; THORACIC AORTA; ULTRACENTRIFUGATION; WESTERN BLOTTING;

ANIMALS; AORTA, THORACIC; APIGENIN; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; GLUCURONIC ACIDS; MALE; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; RATS; RATS, WISTAR;

EID: 84863016114     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05645.x     Document Type: Article

References (29)

1. Yamagishi S, Imaizumi T. Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy. Curr. Pharm. Des. 2005; 11: 2279-99.
2. Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol. Res. 2007; 55: 498-510.
3. Creager MA, Lüscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003; 108: 1527-32.
4. Idris I, Gray S, Donnelly R. Protein kinase C activation: Isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 2001; 44: 659-73.
5. Steinberg SF Structural basis of protein kinase C isoform function. Physiol. Rev. 2008; 88: 1341-78.
6. Zhou H, Chen S, Wang L, He Q, Fan X. Regulation of the expression of pulmonary arterial collagen by protein kinase C and breviscapine in chronic hypoxic rats. Zhonghua Jie He He Hu Xi Za Zhi 2002; 25: 347-51 (in Chinese).
7. Zhang SJ, Song Y, Zhai WLet al.Breviscapine alleviates hepatic injury and inhibits PKC-mRNA and its protein expression in brain-dead BA-Ma mini pigs. Hepatobiliary Pancreat. Dis. Int. 2007; 6: 604-9.
8. Zhou W, Wang XL, Lamping KG, Lee HC. Inhibition of protein kinase C beta protects against diabetes induced impairment in arachidonic acid dilation of small coronary arteries. J. Pharmacol. Exp. Ther. 2006; 319: 199-207.
9. Wang M, Zhang WB, Zhu JH, Fu GS, Zhou BQ. Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway. Acta Pharmacol. Sin. 2009; 30: 1081-91.
10. Zhu BH, Guan YY, He H, Lin MJ. Erigeron breviscapus prevents defective endothelium-dependent relaxation in diabetic rat aorta. Life Sci. 1999; 65: 1553-9.
11. Way KJ, Katai N, King GL. Protein kinase C and the development of diabetic vascular complications. Diabet. Med. 2001; 18: 945-59.
12. Wickley PJ, Ding XQ, Murray PA, Damron DS. Propofol-induced activation of protein kinase C isoforms in adult rat ventricular myocytes. Anesthesiology 2006; 104: 970-7.
13. Zhu LH, Wang L, Wang Det al.Puerarin attenuates high-glucose-and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCα2/Rac1-dependent signaling. Free Radic. Biol. Med. 2010; 48: 471-82.
14. Li X, Hahn CN, Parsons M, Drew J, Vadas MA, Gamble JR. Role of protein kinase C-zeta in thrombin-induced endothelial permeability changes: Inhibition by angiopoietin-1. Blood 2004; 104: 1716-24.
15. Inoue M, Kishimoto A, Takai Y, Nishizuka Y. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J. Biol. Chem. 1977; 252: 7610-6.
16. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc. Natl Acad. Sci. USA 1992; 89: 11059-63.
17. Kikkawa R, Haneda M, Uzu T, Koya D, Sugimoto T, Shigeta Y. Translocation of protein kinase C alpha and zeta in rat glomerular mesangial cells cultured under high glucose conditions. Diabetologia 1994; 37: 838-41.
18. Mackay K, Mochly-Rosen D. Localization, anchoring, and functions of protein kinase C isozymes in the heart. J. Mol. Cell. Cardiol. 2001; 33: 1301-7.
19. Jiang JH, Yuen V, Xiang H, McNeill JH. Improvement in cardiac function of diabetic rats by bosentan is not associated with changes in the activation of PKC isoforms. Mol. Cell. Biochem. 2006; 282: 177-85.
20. Geraldes P, Hiraoka-Yamamoto J, Matsumoto Met al.Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat. Med. 2009; 15: 1298-306.
21. Leitges M, Mayr M, Braun Uet al.Exacerbated vein graft arteriosclerosis in protein kinase C-delta-null mice. J. Clin. Invest. 2001; 108: 1505-12.
22. Sunesson L, Hellman U, Larsson C. Protein kinase C epsilon binds peripherin and induces its aggregation, which is accompanied by apoptosis of neuroblastoma cells. J. Biol. Chem. 2008; 283: 16653-64.
23. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications. Proc. Natl Acad. Sci. USA 1992; 15: 12043-7.
24. Ishii H, Jirousek MR, Koya Det al.Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 1996; 272: 728-31.
25. Kim JH, Kim JH, Jun HO, Yu YS, Kim KW. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy. Am. J. Pathol. 2010; 176: 1517-24.
26. Rosales OR, Isales CM, Bhargava J. Overexpression of protein kinase C alpha and beta1 has distinct effects on bovine aortic endothelial cell growth. Cell. Signal. 1998; 10: 589-97.
27. Zhu BH, Guan YY, He H, Lin MJ. Effects of scutellarein on diabetic rat aorta. Acta Pharmacol. Sin. 2000; 21: 353-6.
28. Gao R, Zhu BH, Tang SB, Wang JF, Ren J. Scutellarein inhibits hypoxia- and moderately-high glucose-induced proliferation and VEGF expression in human retinal endothelial cells. Acta Pharmacol. Sin. 2008; 29: 707-12.
29. Luo P, Tan ZH, Zhang ZF, Zhang H, Liu XF, Mo ZJ. Scutellarin isolated from Erigeron multiradiatus inhibits high glucose-mediated vascular inflammation. Yakugaku Zasshi 2008; 128: 1293-9 (in Japanese).